TABLE 4.
Multivariable multistate modeling regression analysis for survivors at risk of cardiomyopathy (1&2 year surveillance frequency) (statistically significant results)
| Parameter | Level | Rate of becoming adherentent | Rate of becoming non‐adher | ||||||
|---|---|---|---|---|---|---|---|---|---|
| RR | 95% LCL | 95% UCL | p<0.05 | RR | 95%LCL | 95%UCL | p<0.05 | ||
| Age | Age at follow‐up start | 0.906 | 0.838 | 0.980 | 0.014 | ||||
| Cardiac surveillance frequency | 2 year versus 1 year | 0.429 | 0.363 | 0.507 | <0.001 | ||||
| Specialized clinic cumulative | 1.113 | 1.048 | 1.181 | 0.001 | |||||
| Specialized clinic previous 1 year | Y versus N | 1.602 | 1.016 | 2.524 | 0.042 | 0.472 | 0.363 | 0.614 | <0.0001 |
| PCP cumulative | 1.066 | 1.010 | 1.126 | 0.021 | |||||
| General cancer clinic cumulative | 1.026 | 1.004 | 1.047 | 0.017 | 0.977 | 0.964 | 0.990 | 0.001 | |
| SES | 2 versus 1 | 1.026 | 0.688 | 1.530 | 0.899 | ||||
| 3 versus 1 | 0.550 | 0.352 | 0.860 | 0.009 | |||||
| 4 versus 1 | 0.703 | 0.470 | 1.053 | 0.088 | |||||
| 5 versus 1 | 0.818 | 0.550 | 1.217 | 0.321 | |||||
| Sex | F versus M | 1.375 | 1.020 | 1.853 | 0.037 | ||||
| Treatment before index | Chemo and chest rad versus chemo only | 1.753 | 1.208 | 2.544 | 0.003 | ||||
Bolded values are statistically significant (p<0.05).